Article
Obesity and familial predisposition are significant determining factors of an adverse metabolic profile in young patients with congenital adrenal hyperplasia.
Hormone research in paediatrics - 1 Jan 2013
Moreira Ricardo P P, Villares Sandra M, Madureira Guiomar, Mendonca Berenice B, Bachega Tânia A S S
Abstract excerpt
BACKGROUND/AIMS: Glucocorticoid (GC) therapy is known to predispose to an adverse metabolic profile. Therefore, we investigated the prevalence of obesity and metabolic syndrome (MetS) in young patients with congenital adrenal hyperplasia (CAH) and to correlate this prevalence with GC treatment and family history. METHODS: The study population consisted of 33 young CAH patients who received cortisone acetate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.